Pantoprazol Juta (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazol Juta, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to manage gastro‑intestinal reflux disease and other acid‑related disorders in adults. GNH USA supplies Pantoprazol Juta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazol Juta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Juta is a proton pump inhibitor that acts on the gastric acid secretion pathway, providing relief in several acid‑related conditions.

- Gastro‑esophageal reflux disease (GERD): alleviates heartburn and esophageal irritation. - Erosive esophagitis: promotes healing of erosive lesions in the esophagus. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the syndrome. - Peptic ulcer disease: supports ulcer healing by reducing gastric acidity. - NSAID‑induced ulcer prophylaxis: lowers risk of ulcer formation in patients regularly using non‑steroidal anti‑inflammatory drugs.

Pantoprazol Juta may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas formation. - Constipation: infrequent bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: kidney inflammation. - Severe hypersensitivity reactions: including rash, angioedema, or anaphylaxis. - Low magnesium levels (hypomagnesemia): may cause muscle cramps or cardiac arrhythmia. - Bone fractures: associated with long‑term use. - Liver enzyme elevation: increased ALT/AST values.

Before initiating therapy with Pantoprazol Juta, consider the following safety measures:

- Assess renal function: adjust use in severe renal impairment. - Review concomitant medications: monitor for interactions that affect drug levels. - Evaluate need for long‑term therapy: limit duration when possible to reduce fracture risk. - Pregnancy and lactation: use only if clearly indicated. - Elderly patients: start with the lowest effective dose and monitor closely. - Store at ambient temperature: keep below 25°C, protect from moisture and light.

Pantoprazol Juta can influence the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketamine  :  risk              ... -  ...    ...  ...  ...  ...  ...  ...  …     …   t   t  

Moderate     t    t      t "  "  " " " " " " "  "  "  "  "  " 

  "  "  t  "  t  "   t  "  "  "  "  "  "  "  "  "  "  " ");